Home Federal Bank Of Tennessee Bristol Myers Squibb CO Transaction History

Home Federal Bank Of Tennessee

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 10, 2020	SELL	$46.4 - $67.43 $146,531 - $212,943	-3,158 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $155,405 - $202,712	3,158 New	3,158 $203,000
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $189,290 - $206,375	-3,158 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $174,416 - $201,290	3,158	3,158 $202,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Home Federal Bank Of Tennessee, based on Form 13F filings with the SEC.

Stay updated on Home Federal Bank Of Tennessee with notifications on news.